Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coeptis Therapeutics Holdings (COEPW) Revenue (2021 - 2025)

Coeptis Therapeutics Holdings has reported Revenue over the past 2 years, most recently at $862049.0 for Q4 2025.

  • Quarterly results put Revenue at $862049.0 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $1.4 million (changed N/A YoY), and the annual figure for FY2025 was $1.4 million, changed.
  • Revenue for Q4 2025 was $862049.0 at Coeptis Therapeutics Holdings, up from $237441.0 in the prior quarter.
  • Over the last five years, Revenue for COEPW hit a ceiling of $4.3 million in Q3 2021 and a floor of -$15.8 million in Q4 2021.